Osiris Therapeutics (OSIR) Declares $0.20 Special Dividend; 1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Osiris Therapeutics Announces Special Dividend
September 17, 2015 8:00 AM EDTCOLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on October 30, 2015 to stockholders of record as of October 16,... More
Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer
September 17, 2015 8:00 AM EDTCOLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today the appointment of Gregory Law, to serve as Chief Financial Officer and Dwayne Montgomery, to serve as Chief Business Officer.
Mr. Law has been... More



